Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Harvard Bioscience, Inc. HBIO
$5.66
-$0.07 (-1.31%)
На 18:00, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
240483000.00000000
-
week52high
6.29
-
week52low
1.98
-
Revenue
113335000
-
P/E TTM
-129
-
Beta
1.64982600
-
EPS
-0.05000000
-
Last Dividend
0.00000000
-
Next Earnings Date
01 авг 2023 г. в 20:00
Описание компании
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Keybanc | Overweight | Overweight | 05 авг 2022 г. |
| Keybanc | Overweight | 10 ноя 2020 г. | |
| Benchmark | Speculative Buy | Speculative Buy | 27 февр 2020 г. |
| Singular Research | Buy | 17 ноя 2016 г. | |
| Benchmark | Buy | 28 июл 2015 г. | |
| Keybanc | Overweight | Overweight | 09 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Green James W | D | 2153302 | 49322 | 01 янв 2023 г. |
| Rossi Michael A. | D | 260540 | 3035 | 29 дек 2022 г. |
| Rossi Michael A. | D | 263575 | 3763 | 29 дек 2022 г. |
| Rossi Michael A. | D | 267338 | 3162 | 29 дек 2022 г. |
| Green James W | D | 2202624 | 23216 | 29 дек 2022 г. |
| Green James W | D | 2225840 | 28784 | 29 дек 2022 г. |
| Green James W | D | 2254624 | 24187 | 29 дек 2022 г. |
| Green James W | A | 2278811 | 15000 | 01 дек 2022 г. |
| Green James W | A | 2263811 | 15000 | 30 ноя 2022 г. |
| LOY BERTRAND | D | 0 | 108715 | 06 сент 2022 г. |
Новостная лента
Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
GlobeNewsWire
02 мая 2023 г. в 17:01
HOLLISTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the Sidoti Micro Cap Virtual Conference taking place on May 10th, 2023.
Why Harvard Bioscience Stock Rose This Week
The Motley Fool
27 апр 2023 г. в 18:14
Harvard Bioscience's shares are up more than 105% so far this year. The company is seeing strong sales from its equipment to aid in CRISPR gene-editing.
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
GlobeNewsWire
17 апр 2023 г. в 16:45
HOLLISTON, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2023 before the market opens on April 25, 2023, and will hold a conference call to discuss the results at 9:00 a.m. Eastern Time.
Harvard Bioscience: Stock To Rise On Long-Term Growth And Attractive Valuation
Seeking Alpha
26 мар 2023 г. в 04:38
Harvard Bioscience is seeing strong order growth for its improved product portfolio. Harvard Bioscience has strong expected earnings growth for 2023 and 2024.
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
GlobeNewsWire
16 мар 2023 г. в 17:14
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the Sidoti Virtual Investor Conference taking place on March 22-23, 2023.